Mark Bouzyk, PhD will serve as the Genetics Core Director. Dr. Bouzyk is the director of the Emory Center for Medical Genomics (CMG), which will house and administer the Genetics Core. The core provides state-of-theart laboratory capabilities to enable high throughput genetic linkage and association studies ranging from candidate gene to genomic screens all supported by a robust and flexible data management infrastructure. Dr Bouzyk recently joined the faculty at Emory with a more than eight year track record in a global pharmaceutical company, GlaxoSmithKline, where he served as Director of Genetic Laboratory Sciences leading the company's high throughput genotyping efforts in Europe. During his time in industry, Dr Bouzyk not only established and managed the high throughput genetic laboratories for GSK, including DMA sample management, sequencing and genotyping, he also delivered key processes for candidate gene and whole genome association studies as well as negotiating key scientific &technological agreements for such genetic projects. This has resulted in an annual turnover of more than 10 million genotypes at GSK with significant preliminary association data in several common diseases, such as diabetes and asthma. In his position at Emory, Dr. Bouzyk serves as the link between the faculty utilizing the services of the core and the technicians analyzing the samples. Under his direction, the Center for Medical Genomics has acquired the equipment and personnel necessary to operate as a high-throughput extraction, sequencing, expression and genotyping facility. Dr. Bouzyk is responsible for working with the faculty to develop workflows for the life cycle of each project, to develop methods to ensure high quality of the data produced by the core, and to identify and acquire new technology and equipment.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Center Core Grants (P30)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
United States
Zip Code
Boros, Benjamin D; Greathouse, Kelsey M; Gentry, Erik G et al. (2017) Dendritic spines provide cognitive resilience against Alzheimer's disease. Ann Neurol 82:602-614
Ivanova, Tamara N; Gross, Christina; Mappus, Rudolph C et al. (2017) Familiarity with a vocal category biases the compartmental expression of Arc/Arg3.1 in core auditory cortex. Learn Mem 24:612-621
Zimmermann, Kelsey S; Yamin, John A; Rainnie, Donald G et al. (2017) Connections of the Mouse Orbitofrontal Cortex and Regulation of Goal-Directed Action Selection by Brain-Derived Neurotrophic Factor. Biol Psychiatry 81:366-377
Eidson, Lori N; Inoue, Kiyoshi; Young, Larry J et al. (2017) Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling. Neuropsychopharmacology 42:661-670
Yang, Su; Yang, Huiming; Chang, Renbao et al. (2017) MANF regulates hypothalamic control of food intake and body weight. Nat Commun 8:579
Francis, Joshua W; Newman, Laura E; Cunningham, Leslie A et al. (2017) A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and ?-Tubulin Is Required for Maintaining the Microtubule Network. J Biol Chem 292:4336-4349
Rorabaugh, Jacki M; Chalermpalanupap, Termpanit; Botz-Zapp, Christian A et al. (2017) Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease. Brain 140:3023-3038
Christopher, Michael A; Myrick, Dexter A; Barwick, Benjamin G et al. (2017) LSD1 protects against hippocampal and cortical neurodegeneration. Nat Commun 8:805
Sharp, W G; Allen, A G; Stubbs, K H et al. (2017) Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodeling. Transl Psychiatry 7:e1157
Kumar, Sandeep; Kang, Dong-Won; Rezvan, Amir et al. (2017) Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation. Lab Invest 97:935-945

Showing the most recent 10 out of 225 publications